The safety of vedolizumab for ulcerative colitis and Crohn's diseaseJean‐Frédéric Colombel, Brian G. Feagan, Remo Panaccione et al.|Gut|2016Cited by 810
Reductions in Corticosteroid Use in Patients with Ulcerative Colitis or Crohnʼs Disease Treated with VedolizumabBruce E. Sands, Brian G. Feagan, Stephen B. Hanauer et al.|The American Journal of Gastroenterology|2013Cited by 6
864 Efficacy of Vedolizumab Induction Therapy in Patients With Crohn's Disease Who Have Experienced Tumor Necrosis Factor Antagonist Failure or Are Tumor Necrosis Factor Antagonist NaiveBruce E. Sands, Irving H. Fox, Brihad Abhyankar et al.|Gastroenterology|2014Cited by 1